Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by market "Europe (incl. UK)", profit streak "≥7 yr", Has report: 33 match(clear filters).

#	Ticker	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Report	FY
1	Games Workshop Group PLC GAW · LSE	$8.0B	94/100 Elite	57.4%low 48.6%	10 yr+	Net cash	70%	Games Workshop: An Exceptional Warhammer Compounder, Priced for Continued ExcellenceJun 26, 2026 · Hold	FY2026
2	Roche Holding AG ROG · SW	$326B	92/100 Elite	39.6%low 26.1%	10 yr+	0.5×	72%	Roche Zen Horizon Framework Deep Dive: A Diagnostics and Pharma Giant Past the Patent Cliff, with a Fair Price and Debated GrowthJun 5, 2026 · Hold	FY2025
3	LOréal S.A. OR · Paris	$222B	88/100 Elite	16.5%low 12.3%	10 yr+	0.1×	73%	L’Oréal: Record First-Half Margins and a Broad-Based Recovery, but 30 Times Earnings Already Prices In the China and Gucci UpsideAug 5, 2026 · Hold	FY2025
4	Novo Nordisk A/S NOVO-B · CO	$210B	88/100 Elite	59.3%low 52.8%	10 yr+	0.5×	84%	Novo Nordisk: A Long-Term Owner's PerspectiveMay 17, 2026 · Watch	FY2025
5	Belimo Holding BEAN · SW	$13B	88/100 Elite	22.5%low 17.7%	10 yr+	Net cash	44%	Belimo Holding: A Premium HVAC Compounder Priced for an AI-Cooling RunwayJun 27, 2026 · Watch	FY2025
6	Givaudan SA GIVN · SW	$38B	86/100 Elite	20.9%low 17.9%	10 yr+	0.8×	42%	Givaudan SA (GIVN.SW) Zen Horizon Research ReportJun 8, 2026 · Watch	FY2025
7	BE Semiconductor Industries NV BESI · Amsterdam	$24B	86/100 Elite	35.2%low 19.0%	10 yr+	Net cash	59%	In-Depth Value Analysis of Besi, a Back-End Advanced Packaging Equipment LeaderJun 4, 2026 · Watch	FY2025
8	Diageo PLC DGE · LSE	$46B	84/100 Elite	34.7%low 20.8%	10 yr+	2.0×	61%	Diageo: Cyclical Trough and Structural Erosion Are Both Real, and at 16.435 Pounds the Discount Is Not Yet Wide EnoughJul 31, 2026 · Hold	FY2025
9	Unilever PLC ULVR · LSE	$130B	83/100 Elite	39.4%low 28.7%	10 yr+	1.6×	43%	Unilever: Q2 Volume Grew 5.5%, the Strongest Quarter in More Than a Decade, but 47.43 Pounds Leaves No Margin of SafetyAug 3, 2026 · Hold	FY2025
10	Dassault Systemes SE DSY · Paris	$28B	83/100 Elite	12.4%low 9.7%	10 yr+	Net cash	84%	Dassault Systèmes: A Zen Horizon Framework Deep-Dive Research ReportJun 4, 2026 · Watch	FY2025
11	BAE Systems plc BA · LSE	$78B	82/100 Elite	20.8%low 14.2%	10 yr+	0.5×	41%	BAE Systems: The Portfolio Moat Is Genuine, but at 20.27 GBP the Rerating Has Already Outrun Earnings GrowthJul 30, 2026 · Hold	FY2025
12	Sika AG SIKA · SW	$37B	80/100 Elite	22.8%low 15.7%	10 yr+	0.7×	45%	Sika AG: Quality Compounder in a Cyclical Air PocketJun 27, 2026 · Hold	FY2025
13	Straumann Holding AG STMN · SW	$20B	80/100 Elite	21.3%low 7.6%	10 yr+	0.1×	74%	Straumann Holding AG: Dental Platform Leader at a Demanding PriceJun 27, 2026 · Hold	FY2025
14	Novartis AG NOVN · SW	$306B	78/100 Strong	20.9%low 9.0%	10 yr+	0.6×	71%	Novartis (NVS) Zen Horizon Research ReportJun 8, 2026 · Hold	FY2025
15	ABB Ltd ABBN · SW	$183B	77/100 Strong	21.9%low 8.1%	10 yr+	0.2×	33%	ABB Ltd Zen Horizon Framework Deep ResearchJun 6, 2026 · Watch	FY2025
16	Thales S.A. HO · Paris	$55B	77/100 Strong	16.8%low 9.5%	10 yr+	0.2×	25%	Thales: A Genuine Defence-Electronics Quality Compounder, Priced Like the Best Case Is Already Locked InJul 7, 2026 · Hold	FY2025
17	Eckert & Ziegler Strahlen- und Medizintechnik AG EUZ · XETRA	$1.0B	76/100 Strong	14.4%low 9.1%	10 yr+	Net cash	48%	Eckert & Ziegler SE: A Better Business, Not Yet a Better PriceJul 15, 2026 · Hold	FY2025
18	Intertek Group PLC ITRK · LSE	$11B	75/100 Strong	30.4%low 22.5%	10 yr+	1.2×	32%	Intertek: Quality Compounder on a Takeover BidJun 17, 2026 · Hold	FY2025
19	SGS SA SGSN · SW	$24B	74/100 Strong	48.5%low 30.6%	10 yr+	3.3×	48%	SGS: High-Quality TIC Compounder at Full ValueJun 17, 2026 · Hold	FY2025
20	UCB SA UCB · BR	$45B	71/100 Strong	10.2%low 3.8%	10 yr+	Net cash	71%	UCB SA: A Specialty-Biopharma Growth Platform That Has Already Re-RatedJun 29, 2026 · Hold	FY2025
21	Bureau Veritas SA BVI · Paris	$13B	70/100 Strong	27.2%low 10.1%	10 yr+	1.0×	30%	Bureau Veritas: Quality TIC, Priced for ReaccelerationJun 17, 2026 · Hold	FY2025
22	Schneider Electric S.E. SU · Paris	$176B	68/100 Strong	12.5%low 8.5%	10 yr+	0.6×	40%	Schneider Electric (SU.PA) Zen Horizon Research ReportJun 5, 2026 · Watch	FY2025
23	ASM International NV ASM · Amsterdam	$42B	67/100 Strong	16.8%low 6.7%	10 yr+	Net cash	47%	ASM International Deep Value Investment AnalysisJun 4, 2026 · Watch	FY2025
24	Hexagon AB (publ) HEXA-B · ST	$25B	67/100 Strong	10.6%low 6.0%	10 yr+	0.3×	64%	Hexagon AB (HEXA-B.ST) Zen Horizon Deep-Dive Research ReportJun 9, 2026 · Watch	FY2025
25	Air Liquide SA AI · Paris	$117B	64/100 Medium	12.3%low 11.0%	10 yr+	0.4×	59%	Air Liquide (AI.PA) Buffett Framework Deep-Dive ResearchJun 9, 2026 · Watch	FY2025
26	Rheinmetall AG RHM · XETRA	$57B	63/100 Medium	13.5%low 0.1%	10 yr+	Net cash	47%	Rheinmetall: Respect Without Urgency for a Re-Rated Defence PrimeJul 23, 2026 · Hold	FY2025
27	Mowi ASA MOWI · OL	$12B	63/100 Medium	16.5%low 4.3%	10 yr+	0.5×	53%	Mowi ASA: A License-Constrained Salmon Platform at a Fair, Not Forgiving, PriceJul 2, 2026 · Hold	FY2025
28	JSC National Atomic Company Kazatomprom KAP · IL	$23B	62/100 Medium	25.5%low 11.8%	10 yr+	—	41%	Kazatomprom (KAP.IL) Zen Horizon Deep-Dive ReportJun 9, 2026 · Watch	FY2025
29	Haleon PLC HLN · LSE	$41B	61/100 Medium	6.3%low 2.4%	7 yr	0.4×	61%	Haleon: Oral Health Supplied Over 90% of First-Half Organic Growth While the Rest of the Portfolio Grew 0.3%, and 3.633 Pounds Leaves No Margin of SafetyAug 1, 2026 · Hold	FY2025
30	Saab AB (publ) SAAB-B · ST	$31B	58/100 Medium	9.3%low 5.0%	10 yr+	Net cash	22%	Saab: Europe's Sovereign Defense Franchise Is Real, but the Margin of Safety Is GoneJul 10, 2026 · Hold	FY2025
31	Compagnie de Saint-Gobain S.A. SGO · Paris	$43B	57/100 Medium	8.7%low 2.2%	10 yr+	0.4×	26%	Saint-Gobain: A Higher Margin Floor Is Proven, but at 74.16 EUR the Price Sits Above the 64 EUR Conservative ValueJul 29, 2026 · Hold	FY2025
32	Fresnillo PLC FRES · LSE	$23B	50/100 Medium	12.3%low 3.7%	10 yr+	Net cash	35%	Fresnillo: A Genuine Re-Rating, But the Price Already Assumes the Hard Part Is DoneJul 4, 2026 · Hold	FY2025
33	Eurofins Scientific SE ERF · Paris	$13B	50/100 Medium	10.6%low 6.1%	10 yr+	1.3×	55%	Eurofins Scientific (Eurofins Scientific SE, ERF.PA) — Zen Horizon ReportJun 8, 2026 · Watch	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.